Alcohol Use Disorder
Alcohol Use Disorder (AUD) is a medical condition characterized by an inability to control or stop drinking despite negative consequences, leading to significant impairment in daily life.
CBD for Alcohol Use Disorder: A Phase II Trial
We are studying whether adding cannabidiol to standard treatment helps patients with severe alcohol use disorder stay abstinent after inpatient care. The trial also looks at the safety of CBD and its effects on withdrawal and anxiety symptoms.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 18 and 75 years old?
- Do you have severe alcohol use problems (AUD) as defined by a doctor?
- Are you currently pregnant or breastfeeding?
- Do you have any serious medical conditions like liver failure or severe kidney problems?
- Are you willing to attend follow-up visits after your treatment?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Arvisol
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Assistance Publique Hopitaux De Paris
Psychiatry Department
Aulnay-sous-Bois, France
University Hospital Of Clermont-Ferrand
Addictology Deparment
Beaumont, France
Assistance Publique Hopitaux De Paris
Addictology Department
Créteil, France
Sponsor: Assistance Publique Hopitaux De Paris
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.